Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP4 | P27487 | 4/20 | 0.53 |
| ▸ | LTA4H | P09960 | 2/20 | 0.50 |
| ▸ | HSD17B1 | P14061 | 2/20 | 0.48 |
| ▸ | HSD17B2 | P37059 | 2/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.47 |
| ▸ | MAPT | P10636 | 3/20 | 0.47 |
| ▸ | LMNA | P02545 | 2/20 | 0.47 |
| ▸ | GAA | P10253 | 2/20 | 0.47 |
| ▸ | GLA | P06280 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 3/20 | 0.46 |
| ▸ | HPGD | P15428 | 3/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.46 |
| ▸ | NPC1 | O15118 | 1/20 | 0.46 |
| ▸ | TP53 | P04637 | 1/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | CASP1 | P29466 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7589651 | 1.00 | DPP4 (0.53) | DPP4LTA4HHSD17B1HSD17B2ALDH1A1 | |
| SCHEMBL14960832 | 1.00 | DPP4 (0.53) | DPP4LTA4HHSD17B1HSD17B2ALDH1A1 | |
| SCHEMBL14960831 | 1.00 | DPP4 (0.53) | DPP4LTA4HHSD17B1HSD17B2ALDH1A1 | |
| SCHEMBL7587637 | 0.96 | DPP4 (0.50) | DPP4LTA4HHSD17B1HSD17B2ALDH1A1 | |
| SCHEMBL23611278 | 0.86 | DPP4 (0.65) | DPP4LTA4HALDH1A1L3MBTL1KDM4E | |
| SCHEMBL13707354 | 0.86 | DPP4 (0.65) | DPP4LTA4HALDH1A1L3MBTL1KDM4E | |
| Alpha-Terthienyl SCHEMBL147274 | 0.86 | DPP4 (0.65) | DPP4LTA4HALDH1A1L3MBTL1KDM4E | |
| SCHEMBL2742433 | 0.86 | DPP4 (0.65) | DPP4LTA4HALDH1A1L3MBTL1KDM4E | |
| SCHEMBL1105086 | 0.86 | DPP4 (0.65) | DPP4LTA4HALDH1A1L3MBTL1KDM4E | |
| SCHEMBL499333 | 0.86 | DPP4 (0.65) | DPP4LTA4HALDH1A1L3MBTL1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 108 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2379109-B1 | COMBINATION OF PHOTODYNAMIC THERAPY AND ANTI-VEGF AGENTS IN THE TREATMENT OF UNWANTED CHOROIDAL NEOVASCULATURE | BAUSCH HEALTH COMPANIES INC (CA) | 2020-10-07 | — | — | EP | disclosed |
| EP-3036782-B1 | NEW ABSORBER FOR ORGANIC HETEROJUNCTION SOLAR CELLS | BASF SE (DE) | 2019-10-09 | — | — | EP | disclosed |
| US-9812263-B2 | Compound and photoelectric conversion device | ADEKA CORPORATION (JP) | 2017-11-07 | — | — | US | disclosed |
| US-9812263-B2 | Compound and photoelectric conversion device | ADEKA CORPORATION (JP) | 2017-11-07 | — | — | US | disclosed |
| US-9805879-B2 | Dye-sensitized solar cell | ADEKA CORPORATION (JP) | 2017-10-31 | — | — | US | disclosed |
| US-9805879-B2 | Dye-sensitized solar cell | ADEKA CORPORATION (JP) | 2017-10-31 | — | — | US | disclosed |
| US-9530571-B2 | Compound and support material supporting this novel compound | ADEKA CORPORATION (JP) | 2016-12-27 | — | — | US | disclosed |
| US-20160211464-A1 | NEW ABSORBER FOR ORGANIC HETEROJUNCTION SOLAR CELLS | BASF SE (DE) | 2016-07-21 | — | — | US | disclosed |
| US-20160211464-A1 | NEW ABSORBER FOR ORGANIC HETEROJUNCTION SOLAR CELLS | BASF SE (DE) | 2016-07-21 | — | — | US | disclosed |
| US-20160211085-A1 | NOVEL COMPOUND AND PHOTOELECTRIC CONVERSION DEVICE | ADEKA CORPORATION (JP) | 2016-07-21 | — | — | US | disclosed |
| EP-0454204-B1 | Method for the photochemical isomeration of organic compounds under the influence of a photosensitizer | DUPHAR INT RES (NL) | 1995-06-28 | — | — | EP | disclosed |
| US-5252191-A | Method for the photochemical isomerization of organic compounds under the influence of a photosensitizer | DUPHAR INTERNATIONAL RESEARCH B.V. (NL) | 1993-10-12 | — | — | US | disclosed |
| US-5158598-A | Insecticides, miticides, and nematocides; nonphytotoxic | BASF AKTIENGESELLSCHAFT (DE) | 1992-10-27 | — | — | US | disclosed |
| EP-0454204-A2 | Method for the photochemical isomeration of organic compounds under the influence of a photosensitizer | DUPHAR INTERNATIONAL RESEARCH B.V (NL) | 1991-10-30 | — | — | EP | disclosed |
| US-4939165-A | Miticides | FMC CORPORATION | 1990-07-03 | — | — | US | disclosed |
| EP-0353667-A1 | Bithienyl derivatives, process for their preparation, and compositions containing them | BASF Aktiengesellschaft (DE) | 1990-02-07 | — | — | EP | disclosed |
| EP-0220573-A1 | Heterocyclic compounds | F. HOFFMANN-LA ROCHE AG (CH) | 1987-05-06 | — | — | EP | disclosed |
| EP-0219525-A1 | PHOTOACTIVE BITHIENYL PESTICIDES | FMC Corporation (US) | 1987-04-29 | — | — | EP | disclosed |
| US-4645777-A | Photoactive bithienyl pesticides | FMC CORPORATION (US) | 1987-02-24 | — | — | US | disclosed |
| WO-1986005949-A1 | PHOTOACTIVE BITHIENYL PESTICIDES | FMC CORPORATION (US) | 1986-10-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160211464-A1 | NEW ABSORBER FOR ORGANIC HETEROJUNCTION SOLAR CELLS | SLC18A2, EPCAM, SLC18A1 | DPP4 3315/4885LTA4H 471/4885HSD17B1 878/4885 |
| US-20160211085-A1 | NOVEL COMPOUND AND PHOTOELECTRIC CONVERSION DEVICE | CYP1B1, PAH, CRY1 | DPP4 4449/4885LTA4H 1060/4885HSD17B1 460/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.